Hospira Symbiq Infusion System 3.13 and earlier allows remote authenticated users to trigger "unanticipated operations" by leveraging "elevated privileges" for an unspecified call to an incorrectly exposed function.
References
Link | Resource |
---|---|
https://ics-cert.us-cert.gov/advisories/ICSA-15-174-01 | Third Party Advisory US Government Resource |
https://ics-cert.us-cert.gov/advisories/ICSA-15-174-01 | Third Party Advisory US Government Resource |
Configurations
Configuration 1 (hide)
AND |
|
History
21 Nov 2024, 02:30
Type | Values Removed | Values Added |
---|---|---|
References | () https://ics-cert.us-cert.gov/advisories/ICSA-15-174-01 - Third Party Advisory, US Government Resource |
Information
Published : 2019-03-23 20:29
Updated : 2024-11-21 02:30
NVD link : CVE-2015-3965
Mitre link : CVE-2015-3965
CVE.ORG link : CVE-2015-3965
JSON object : View
Products Affected
pfizer
- symbiq_infusion_system
- symbiq_infusion_system_firmware
CWE
CWE-264
Permissions, Privileges, and Access Controls